4 free views remaining today
focal segmental glomerulosclerosis 5
ICD-10 Codes
Related ICD-10:
Description
Focal Segmental Glomerulosclerosis (FSGS) Description
FSGS is a rare type of kidney disease that causes scarring in some parts of the kidney filters, known as glomeruli. This condition affects the tiny filters in the kidneys, which are responsible for filtering waste from the blood.
- Glomerular Damage: In FSGS, only some of the glomeruli are damaged, leading to scarring and a reduction in their ability to filter waste from the blood.
- Segmental Scarring: The scarring is not uniform and affects only parts of the glomeruli, hence the term "segmental".
- Kidney Function Impairment: As a result of the damage, the kidneys' filtering function is impaired, leading to an accumulation of waste products in the blood.
References
[5] - FSGS is a rare type of kidney disease that causes scarring in some parts of the kidney filters, known as glomeruli.
Additional Characteristics
- FSGS is a rare type of kidney disease that causes scarring in some parts of the kidney filters, known as glomeruli.
- This condition affects the tiny filters in the kidneys, which are responsible for filtering waste from the blood.
- * Glomerular Damage: In FSGS, only some of the glomeruli are damaged, leading to scarring and a reduction in their ability to filter waste from the blood.
- * Segmental Scarring: The scarring is not uniform and affects only parts of the glomeruli, hence the term "segmental".
- * Kidney Function Impairment: As a result of the damage, the kidneys' filtering function is impaired, leading to an accumulation of waste products in the blood.
Signs and Symptoms
Symptoms of Focal Segmental Glomerulosclerosis (FSGS)
FSGS can manifest with a variety of symptoms, which may vary in severity and frequency among individuals. Some common signs and symptoms include:
- Foamy urine: Excess protein in the urine can cause it to appear foamy or cloudy.
- Poor appetite: Many people with FSGS experience a decrease in appetite, leading to weight loss.
- Swelling (edema): Fluid retention can cause swelling in various parts of the body, such as the legs, feet, and face.
- Weight gain: Edema and fluid retention can also lead to weight gain.
These symptoms may appear suddenly or develop gradually over time. It's essential to note that not everyone with FSGS will experience all of these symptoms, and their severity can vary from person to person.
References:
- [5] Symptoms · Foamy urine (from excess protein in the urine) · Poor appetite · Swelling, called generalized edema, from fluids held in the body · Weight gain ...
- [6] Symptoms · Foamy urine (from excess protein in the urine) · Poor appetite · Swelling, called generalized edema, from fluids held in the body · Weight gain ...
- [9] Symptoms of focal segmental glomerulosclerosis · Foamy urine caused by large amounts of protein · Low serum albumin due to loss of protein · Weight gain caused by ...
Additional Symptoms
- Poor appetite
- Swelling (edema)
- Foamy urine
- weight gain
Diagnostic Tests
Treatment
Treatment Options for Focal Segmental Glomerulosclerosis (FSGS)
According to various medical sources, the treatment options for FSGS include:
- Corticosteroids: These are often used as a first-line treatment for idiopathic FSGS with nephrotic syndrome [2].
- Immunosuppressive drugs: These may be prescribed in cases where corticosteroid therapy is not effective or if the patient experiences steroid resistance or dependence [2].
- Plasmapheresis: This is a process that involves removing antibodies from the blood to help reduce inflammation and slow disease progression [5].
- ACE inhibitors and ARBs: These medications can help lower blood pressure and may be used in conjunction with other treatments to manage FSGS symptoms [6].
- Diuretics: These can help remove excess fluid from the body, which is often a symptom of FSGS [3].
It's essential to note that while these treatment options can help slow disease progression or alleviate symptoms, they do not cure FSGS. The disease is chronic and cannot be reversed with treatment alone [4].
Recommended Medications
- Corticosteroids
- Diuretics
- Plasmapheresis
- ACE inhibitors and ARBs
- Immunosuppressive drugs
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for focal segmental glomerulosclerosis (FSGS) involves a range of conditions that can present with similar symptoms and histopathological findings.
Conditions to Consider:
- Minimal change disease: This is a condition where the kidneys appear normal under light microscopy, but electron microscopy reveals podocyte foot process effacement. It is often difficult to distinguish from FSGS in small biopsy samples.
- Membranous nephropathy: This is a condition characterized by thickening of the glomerular basement membrane and deposition of immune complexes. It can present with similar symptoms to FSGS, including proteinuria and hematuria.
- IgA nephropathy: This is a condition where IgA antibodies are deposited in the glomeruli, leading to inflammation and damage. It can present with similar symptoms to FSGS, including hematuria and proteinuria.
- Alport syndrome: This is a genetic disorder that affects the kidneys, ears, and eyes. It can present with similar symptoms to FSGS, including hematuria and proteinuria.
Key Features to Distinguish FSGS from Other Conditions:
- The presence of segmental sclerosis in some glomeruli (as seen on light microscopy)
- Podocyte injury and foot process effacement (as seen on electron microscopy)
- Proteinuria and hematuria
- Normal kidney function at presentation
Genetic Screening:
- Genetic screening may be necessary to distinguish FSGS from other conditions, particularly in cases where the diagnosis is uncertain.
References:
[5] by B Sprangers · 2016 · Cited by 52 — A biopsy is necessary to establish the diagnosis of FSGS and determine the subtype of FSGS. Genetic screening of patients with steroid-resistant ...
Additional Differential Diagnoses
- Membranous nephropathy
- IgA nephropathy
- Minimal change disease
- Alport syndrome
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_5465
- owl#annotatedSource
- t374903
- 22-rdf-syntax-ns#first
- t4027576
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0111130
- core#notation
- DOID:0111130
- oboInOwl#hasDbXref
- MIM:613237
- IAO_0000115
- A focal segmental glomerulosclerosis that has_material_basis_in an autosomal dominant mutation of the INF2 gene on chromosome 14q32.33.
- rdf-schema#label
- focal segmental glomerulosclerosis 5
- oboInOwl#hasExactSynonym
- FSGS5
- rdf-schema#subClassOf
- t375229
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- relatedICD
- http://example.org/icd10/N04.1
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.